Clinical practice guide for the choice of perioperative volume-restoring fluid in adult patients undergoing non-cardiac surgery;Guía de práctica clínica para la elección del fluido de restauración volémica perioperatoria en los pacientes adultos intervenidos de cirugía no cardiaca

Revista Espanola de Anestesiologia y Reanimacion

Volumn 63, Issue 1, 2016, Pages 29-47

  Basora, M ^a   Colomina, M J ^b   Moral, V ^c   Asuero de Lis, M S ^d   Boix, E ^e   Jover, J L ^f   Llau, J V ^g   Rodrigo, M P ^h   Ripolles J ⁱ   Calvo Vecino, J M ⁱ  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Hospital Sant Pau   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e Servicio de Medicina Preventiva   (Spain)

^f Hospital Verge dels Lliris   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^h HOSPITAL DE BASURTO   (Spain)

ⁱ HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

Author keywords

Clinical practice guide; Colloids; Fluid therapy; Perioperative period; Surgery

Indexed keywords

COLLOID; HETASTARCH DERIVATIVE;

ADULT; COLLOID; FLUID THERAPY; HUMAN; PERIOPERATIVE PERIOD; THERAPEUTIC USE;

ADULT; COLLOIDS; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; PERIOPERATIVE CARE;

EID: 84940749218     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2015.06.013     Document Type: Article

References (79)

1. Lowell J.A., Schifferdecker C., Driscoll D.F., Benotti P.N., Bistrian B.R. Postoperative fluid overload: not a benign problem. Crit Care Med. 1990, 18:728-733.
2. Chappell D., Jacob M., Hofmann-Kiefer K., Conzen P., Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008, 109:723-740.
3. Powell-Tuck J, Gosling P, Lobo DN, Allison SP, Carlson GL, Marcus Gore British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients. GIFTASUP 2011; March.
4. Vallet B., Blanloeil Y., Cholley B., Orliaguet G., Pierre S., Tavernier B. Guidelines for perioperative haemodynamic optimization. Ann Fr Anesth Reanim. 2013, 32:e151-e158.
5. National Institute for Health and Care Excellence. Intravenous fluid therapy. Intravenous fluid therapy in adults in hospital. Disponible en: https://www.nice.org.uk/guidance/cg1742015 (Guideline Ref ID 38 CG174).
6. Corcoran T., Rhodes J.E., Clarke S., Myles P.S., Ho K.M. Perioperative fluid management strategies in major surgery: A stratified meta-analysis. Anesth Analg. 2012, 114:640-651.
7. Cecconi M., Corredor C., Arulkumaran N., Abuella G., Ball J., Grounds R.M., et al. Clinical review: Goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups. Crit Care. 2013, 17:209.
8. Wise J. Boldt: The great pretender. BMJ. 2013, 346:f1738.
9. Shafer S.L. Notice of retraction. Anesth Analg. 2010, 111:1567.
10. EMA/349341/2013. PRAC recommends suspending marketing authorisations for infusion solutions containing hydroxyethyl-starch [consultado Jun 2014]. Disponible en: http://www.ema.europe.eu/docs/en_GB/document:library/press_release/2013/06/wc500144446.pdf.
11. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345:1368-1377.
12. Brandstrup B., Tonnesen H., Beier-Holgersen R., Hjortso E., Ording H., Lindorff-Larsen K., et al. Effects of intravenous fluid restriction on postoperative complications: Comparison of two perioperative fluid regimens: A randomized assessor-blinded multicenter trial. Ann Surg. 2003, 238:641-648.
13. Pearse R.M., Ackland G.L. Perioperative fluid therapy. BMJ. 2012, 344:e2865.
14. Myburgh J.A., Mythen M.G. Resuscitation fluids. N Engl J Med. 2013, 369:1243-1251.
15. Basora M., Moral V., Llau J.V., Silva S. Perioperative colloid administration: a survey of Spanish anesthesiologists' attitudes. Rev Esp Anestesiol Reanim. 2007, 54:162-168.
16. Myburgh J.A. Fluid resuscitation in acute medicine: What is the current situation. J Intern Med. 2015, 277:58-68.
17. McDermid R.C., Raghunathan K., Romanovsky A., Shaw A.D., Bagshaw S.M. Controversies in fluid therapy: Type, dose and toxicity. World J Crit Care Med. 2014, 3:24-33.
18. Jacob M., Chappell D., Rehm M. The 'third space' - fact or fiction?. Best Pract Res Clin Anaesthesiol. 2009, 23:145-157.
19. Gould T.H., Grace K., Thorne G., Thomas M. Effect of thoracic epidural anaesthesia on colonic blood flow. Br J Anaesth. 2002, 89:446-451.
20. Biais M., Bernard O., Ha J.C., Degryse C., Sztark F. Abilities of pulse pressure variations and stroke volume variations to predict fluid responsiveness in prone position during scoliosis surgery. Br J Anaesth. 2010, 104:407-413.
21. Raghunathan K., Shaw A.D., Bagshaw S.M. Fluids are drugs: type, dose and toxicity. Curr Opin Crit Care. 2013, 19:290-298.
22. Basora M., Llau J.V. Survey on the perioperative use of colloids. Rev Esp Anestesiol Reanim. 2004, 51:479.
23. Raghunathan K., Murray P.T., Beattie W.S., Lobo D.N., Myburgh J., Sladen R., et al. Choice of fluid in acute illness: what should be given? An international consensus. Br J Anaesth. 2014, 113:772-783.
24. Shaw A.D., Bagshaw S.M., Goldstein S.L., Scherer L.A., Duan M., Schermer C.R., et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012, 255:821-829.
25. Krajewski M.L., Raghunathan K., Paluszkiewicz S.M., Schermer C.R., Shaw A.D. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg. 2015, 102:24-36.
26. Orbegozo C.D., Gamarano B.T., Njimi H., Vincent J.L. Crystalloids versus colloids: Exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg. 2015, 120:389-402.
27. Vincent J.L., Russell J.A., Jacob M., Martin G., Guidet B., Wernerman J., et al. Albumin administration in the acutely ill: What is new and where next?. Crit Care. 2014, 18:231.
28. Ficha técnica de la albúmina humana. 2015 [consultado acceso 27 Abr 2015]. Disponible en: http://www.aemps.gob.es/cima/pdfs/es/ft/70738/FT_70738.pdf.
29. Caironi P., Tognoni G., Masson S., Fumagalli R., Pesenti A., Romero M., et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014, 370:1412-1421.
30. Hartog C.S., Kohl M., Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg. 2011, 112:635-645.
31. Ficha técnica de la gelatine. 2015 [consultado 27 Abr 2015]. Disponible en: http://www.aemps.gob.es/cima/pdfs/es/ft/61627/FT_61627.pdf.
32. Thompson W.L. Hydroxyethyl starch. Dev Biol Stand. 1980, 48:259-266.
33. Bunn F., Trivedi D. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev. 2012, 7:CD001319.
34. Chappell D., Jacob M. Protocols, physiology, and trials of hydroxyethyl starch. N Engl J Med. 2012, 367:1266.
35. Groeneveld A.B., Navickis R.J., Wilkes M.M. Update on the comparative safety of colloids: A systematic review of clinical studies. Ann Surg. 2011, 253:470-483.
36. Langeron O., Doelberg M., Ang E.T., Bonnet F., Capdevila X., Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg. 2001, 92:855-862.
37. Raghunathan K., Miller T.E., Shaw A.D. Intravenous starches: Is suspension the best solution. Anesth Analg. 2014, 119:731-736.
38. Van der Linden P., James M., Mythen M., Weiskopf R.B. Safety of modern starches used during surgery. Anesth Analg. 2013, 116:35-48.
39. Ficha técnica del hidroxietilalmidón. 2015 [consultado 27 Abr 2015]. Disponible en: http://www.aemps.gob.es/cima/pdfs/es/ft/64001/FT_64001.pdf.
40. Grupo de trabajo sobre GPC. Elaboración de Guías de Práctica Clínica en el Sistema Nacional de Salud. Manual Metodológico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragonés de Ciencias de la Salud-I+CS. Guías de Práctica Clínica en el SNS: I+CSN° 2006/0I 2007.
41. Alonso-Coello P., Rigau D., Sanabria A.J., Plaza V., Miravitlles M., Martinez L. Quality and strength: The GRADE system for formulating recommendations in clinical practice guidelines. Arch Bronconeumol. 2013, 49:261-267.
42. Rasmussen K.C., Johansson P.I., Hojskov M., Kridina I., Kistorp T., Thind P., et al. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: Results from a randomized controlled trial. Ann Surg. 2014, 259:249-254.
43. Jacob M., Chappell D. Effects of perioperative fasting on haemodynamics and intravascular volumes. Best Pract Res Clin Anaesthesiol. 2012, 26:421-430.
44. Canet J., Gallart L., Gomar C., Paluzie G., Vallès J., Castillo J., et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010, 113:1338-1350.
45. Perner A., Haase N., Wetterslev J., Aneman A., Tenhunen J., Guttormsen A.B., et al. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S-Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial. Trials. 2011, 12:24.
46. Guidet B., Martinet O., Boulain T., Philippart F., Poussel J.F., Maizel J., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care. 2012, 16:R94.
47. Myburgh J.A., Finfer S., Bellomo R., Billot L., Cass A., Gattas D., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012, 367:1901-1911.
48. Annane D., Siami S., Jaber S., Martin C., Elatrous S., Declère A.D., et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA. 2013, 310:1809-1817.
49. Zarychanski R., Abou-Setta A.M., Turgeon A.F., Houston B.L., McIntyre L., Marshall J.C., et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis. JAMA. 2013, 309:678-688.
50. Yang J., Wang W.T., Yan L.N., Xu M.Q., Yang J.Y. Alternatives to albumin administration in hepatocellular carcinoma patients undergoing hepatectomy: An open, randomized clinical trial of efficacy and safety. Chin Med J (Engl.) 2011, 124:1458-1464.
51. Hamaji A., Hajjar L., Caiero M., Almeida J., Nakamura R.E., Osawa E.A., et al. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection. Rev Bras Anestesiol. 2013, 63:27-35.
52. Yates D.R., Davies S.J., Milner H.E., Wilson R.J. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. Br J Anaesth. 2014, 112:281-289.
53. Feldheiser A., Pavlova V., Bonomo T., Jones A., Fotopoulou C., Sehouli J., et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth. 2013, 110:231-240.
54. ®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: A prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol. 2008, 25:986-994.
55. Mahmood A., Gosling P., Vohra R.K. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg. 2007, 94:427-433.
56. Mukhtar A., Aboulfetouh F., Obayah G., Salah M., Emam M., Khater Y., et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: A comparison with human albumin. Anesth Analg. 2009, 109:924-930.
57. Wu Y., Wu A.S., Wang J., Tian M., Jia X.Y., Rui Y., et al. Effects of the novel 6% hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation. Chin Med J (Engl.) 2010, 123:3079-3083.
58. Yassen A.M., Elshoubari M.M., Salah T., Sultan A.M., Flsadany MM, Wahab M.A. Does co-Ad ministration of HES 130/0.4 to albumin 4% affect the transfusion requirements and coagulation profile in living-donor liver transplantation?. Liver Transpl 2011, 17(Suppl 1):S133.
59. Chappell D., Jacob M. Role of the glycocalyx in fluid management: Small things matter. Best Pract Res Clin Anaesthesiol. 2014, 28:227-234.
60. Evans P.A., Heptinstall S., Crowhurst E.C., Davies T., Glenn J.R., Madira W., et al. Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery. J Thromb Haemost. 2003, 1:2140-2148.
61. Perel P., Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2012, 6:CD000567.
62. Fries D., Streif W., Margreiter J., Klingler A., Kühbacher G., Schobersberger W., et al. The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis. Blood Coagul Fibrinolysis. 2004, 15:213-219.
63. Hung M.H., Zou C., Lin F.S., Lin C.J., Chan K.C., Chen Y. New 6% hydroxyethyl starch 130/0.4 does not increase blood loss during major abdominal surgery - a randomized, controlled trial. J Formos Med Assoc. 2014, 113:429-435.
64. Gillies M.A., Habicher M., Jhanji S., Sander M., Mythen M., Hamilton M., et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: Systematic review and meta-analysis. Br J Anaesth. 2014, 112:25-34.
65. Innerhofer P., Fries D., Margreiter J., Klingler A., Kühbacher G., Wachter B., et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg. 2002, 95:858-865.
66. Jin S.L., Yu B.W. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms. Clin Appl Thromb Hemost. 2010, 16:91-98.
67. Parker M.J., Griffiths R., Boyle A. Preoperative saline versus gelatin for hip fracture patients; a randomized trial of 396 patients. Br J Anaesth. 2004, 92:67-70.
68. Saw M.M., Chandler B., Ho K.M. Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: A meta-analysis. Anaesth Intensive Care. 2012, 40:17-32.
69. Mutter T.C., Ruth C.A., Dart A.B. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013, 7:CD00759.
70. Toomtong P., Suksompong S. Intravenous fluids for abdominal aortic surgery. Cochrane Database Syst Rev. 2010, CD000991.
71. Kim D.H. Seventy-two hour peri-operative volume replacement with 6% HES 130/0.4 vs. 20% albumin in patients undergoing abdominal, cranial, and orthopedic surgery. Anesth Pain Med. 2009, 4:235-241.
72. Liang H., Yang C-H., Li H. Effects of preoperative acute hypervolemic hemodilution on hypercoagulability of patients with colon cancer. Ai Zheng. 2006, 25:1256-1260.
73. Mittermayr M., Streif W., Haas T., Fries D., Velik-Salchner C., Klingler A., et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: The role of fibrinogen administration. Anesth Analg. 2007, 105:905-917.
74. Staikou C., Paraskeva A., Fassoulaki A. The impact of 30ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery. Indian J Med Res. 2012, 136:445-450.
75. Topcu I., Civi M., Ozturk T., Keleş G.T., Coban S., Yentür E.A., et al. Evaluation of hemostatic changes using n thromboelastography after crystalloid or colloid fluid administration during major orthopedic surgery. Braz J Med Biol Res. 2012, 45:869-874.
76. Volta C.A., Alvisi V., Campi M., Marangoni E., Alvisi R., Castellazzi M., et al. Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: An in vitro and in vivo study. Anesthesiology. 2007, 106:85-91.
77. Gattas D.J., Dan A., Myburgh J., Billot L., Lo S., Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013, 39:558-568.
78. Zdolsek H.J., Vegfors M., Lindahl T.L., Tornquist T., Bortnik P., Hahn R.G. Hydroxyethyl starches and dextran during hip replacement surgery: Effects on blood volume and coagulation. Acta Anaesthesiol Scand. 2011, 55:677-685.
79. Navarro L.H., Bloomstone J.A., Auler J.O., Cannesson M., Rocca G.D., Gan T.J., et al. Perioperative fluid therapy: A statement from the international Fluid Optimization Group. Perioper Med. (Lond) 2015, 4:3.